Skip to content

Tectonic Therapeutics TECX Total Current Liabilities

Total Current Liabilities at other companies

ALN
Alnylam PharmaceuticalsALNY
$1.35B+25.5%
Septerna, Inc. logo
Septerna, Inc.SEPN
$78.17M+635%
Regenxbio logo
RegenxbioRGNX
$71.11M-33.4%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$19.79M+4.2%
Opko Health logo
Opko HealthOPK
$148.38M-49.8%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$79.6M-31.2%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's total current liabilities?
Tectonic Therapeutics (TECX) reported total current liabilities of $12.96M in Q1 2026.
How has Tectonic Therapeutics's total current liabilities changed year-over-year?
Tectonic Therapeutics's total current liabilities decreased by 4.1% year-over-year, from $13.51M to $12.96M.
What is the long-term trend for Tectonic Therapeutics's total current liabilities?
Over 5 years (2020 to 2025), Tectonic Therapeutics's total current liabilities has grown at a -10.3% compound annual growth rate (CAGR), from $16.61M to $9.67M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.